The biggest concern with Redux is an increased risk of primary pulmonary hypertension

June 1996

The biggest concern with Redux is an increased risk of primary pulmonary hypertension. This is serious...high blood pressure in the lungs can lead to heart failure and death.

Many patients are asking about this...especially after the sensationalized program on PrimeTime Live.

This risk is associated with using ANY of the prescription appetite suppressants for more than 3 months. This includes Redux as well as fenfluramine, phentermine, etc.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote